$9.35 -5.2% vs prev close
NEOG Stock Price vs. AI Score Data gathered: March 12
3M 36.3%

About Neogen

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide.


Neogen
Price $9.35
Target Price Sign up
Volume 3,170,354
Market Cap $2.1B
Year Range $4.65 - $11.33
Dividend Yield 0%
PE Ratio 865
Analyst Rating 50% buy
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '25225M118M107M-16M23M0.100
Q3 '25209M137M72M36M89M0.040
Q2 '25225M156M69M-612M-584M0.050
Q1 '25221M134M87M-11M37M0.100
Q4 '24231M142M90M-456M-428M0.110

Insider Transactions View All

Nassif Mikheal filed to buy 704 shares at $10.9.
February 17 '26
Nassif Mikheal filed to buy 681 shares at $10.
February 2 '26
Nassif Mikheal filed to buy 657 shares at $9.9.
February 2 '26
Nassif Mikheal filed to buy 632 shares at $9.3.
January 16 '26
Nassif Mikheal filed to buy 495 shares at $6.3.
November 7 '25

FAQ - Neogen

The Market Cap of Neogen is $2.1B.

As of today, Neogen's PE (Price to Earnings) ratio is 865.

Currently, the price of one share of Neogen stock is $9.35.

The NEOG stock price chart above provides a comprehensive visual representation of Neogen's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Neogen shares. Our platform offers an up-to-date NEOG stock price chart, along with technical data analysis and alternative data insights.

As of our latest update, Neogen (NEOG) does not offer dividends to its shareholders. Investors interested in Neogen should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

Some of the similar stocks of Neogen are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.